Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 2 Stomach Neoplasms 1 Polycystic Ovary Syndrome 1 Peritoneal Metastases From Gastric Cancer 1 Peritoneal Metastases From Colorectal Cancer 1 Complex Ovarian Cyst 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Radiosurgery 24 lenvatinib 19 Radiofrequency Ablation 16 Hepatectomy 13 Sorafenib 12 Surgical Procedures, Operative 9 Radiotherapy 9 camrelizumab 7 Magnetic Resonance Spectroscopy 7 Blood Specimen Collection 7 Bevacizumab 7 sintilimab 6 apatinib 6 Immune Checkpoint Inhibitors 6 Electroporation 6 atezolizumab 5 tislelizumab 4 Yttrium-90 4 Proton Therapy 4 Oxaliplatin 4 Liver Transplantation 4 Doxorubicin 4 Control Groups 4 Cisplatin 4 Chemoembolization, Therapeutic 4 Catheter Ablation 4 spartalizumab 3 entecavir 3 X-Rays 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Hepatocellular × Laparotomy × Clear all

NCT04791735 2025-05-28

LapCHC

Assistance Publique - Hôpitaux de Paris

Phase NA Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡